Rubius Therapeutics, Inc. - 78116T103
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2022
· Q3 2022
Value (USD)
Total reported value ($000)
$3.652M
QoQ value delta ($000)
-$6.57M
(-64.27%)
Implied price effect (QoQ)
-60.36%
Shares
Total shares
21,245,117
QoQ shares delta
-2,324,856
(-9.86%)
Total shares held by funds (by quarter)
Top holders (Q4 2022)
Top 25 only
Full list
Early Q1 2023 data: only 3 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| FMR LLC | 2,129 | 12,376,153 | 0.0% |
| BAILLIE GIFFORD & CO | 837 | 4,869,126 | 0.0% |
| VANGUARD GROUP INC | 293 | 1,676,669 | 0.0% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 110 | 640,000 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 70 | 412,218 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 35 | 200,190 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 29 | 169,571 | 0.0% |
| DEUTSCHE BANK AG\ | 26 | 150,000 | 0.0% |
| STATE STREET CORP | 25 | 147,789 | 0.0% |
| CITADEL ADVISORS LLC | 22 | 132,922 | 0.0% |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 17 | 102,251 | 0.0% |
| UBS Group AG | 13 | 72,662 | 0.0% |
| NORTHERN TRUST CORP | 12 | 71,366 | 0.0% |
| MORGAN STANLEY | 10 | 62,273 | 0.0% |
| LPL Financial LLC | 6 | 39,307 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 4 | 25,200 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 3 | 19,286 | 0.0% |
| GOLDMAN SACHS GROUP INC | 3 | 17,511 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 3 | 19,200 | 0.0% |
| Bank of New York Mellon Corp | 3 | 20,990 | 0.0% |
| GROUP ONE TRADING, L.P. | 1 | 9,920 | 0.0% |
| BNP PARIBAS ARBITRAGE, SNC | 1 | 6,108 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 2,196 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 314 | 0.0% |
| CITIGROUP INC | 0 | 1,342 | 0.0% |